CLINICAL_TRIALS trial_result · 2009-12-03

Clinical Trial Update: Albuterol HFA MDI in Pediatric Participants With Asthma [Phase 3]

Phase 3 trial update for Albuterol HFA MDIs in pediatric asthma participants has completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2009-12-03